Life Sciences market news & reports

Bridgepoint to acquire Obagi Medical from Waldencast

Mid-market private equity firm Bridgepoint Group has agreed to acquire US-based Obagi Medical, a dermatological skincare and aesthetics business, from Nasdaq-listed beauty and wellness group Waldencast, for an enterprise value of up to $460 million (~€399.00 million).

June 11, 2026

FREE BLOG London Tech Week 2026- How do we talk about healthcare in the context of tech and AI?

This week I attended London Tech Week. Much like last year, AI remained the key focus across all sessions and high-level talks. How are we now talking about AI in healthcare?

June 11, 2026

Bregal Sagemount and Ardian invest in Ennov

Ennov, a France-based life sciences software company, has secured a growth investment led by US private equity firm Bregal Sagemount, with participation from private investment firm Ardian.

May 27, 2026

Healthcare deal activity expected to be increasingly back-end loaded through 2026: Hedley Goldberg, Rothschild & Co

The global healthcare M&A landscape in 2026 sits at an unusual juncture. The wider economy is facing a lot of headwinds and feels increasingly uncertain, whilst the usual private equity strategies aren’t working as smoothly as before. Healthcare is still seen as one of the strongest sectors to invest in around the world, however, and may even benefit from the shift away from software and tech-enabled services.

May 22, 2026

French PE firm Lauxera raises $604 million Growth II fund

Paris based private equity firm Lauxera Capital Partners has closed its second growth equity fund, Lauxera Growth II, at €520 million, almost double its predecessor, which closed at €260 million in 2021.

May 21, 2026

Isomorphic Labs raises $2.1bn

Isomorphic Labs, a London-based AI drug design and development company, has raised $2.1 billion in funding led by American venture capital firm Thrive Capital. Google Ventures. Tech giant Alphabet's independent venture capital arm, alongside specialist technology investment firm MGX, global investment firm Temasek, Alphabet's independent growth equity fund CapitalG, and the UK Sovereign AI Fund, the British government’s £500 million ($670.32 mn) venture fund, also invested in the firm.

May 21, 2026

Private equity has record dry powder, but mid-market healthcare assets remain tightly held — John DiGiovanni, Inflexion

HBI spoke with John DiGiovanni, recently appointed Head of Healthcare at European mid-market private equity firm Inflexion. DiGiovanni discusses Inflexion’s healthcare strategy for 2026, trends in pharma services and medtech, and the broader market forces shaping its investment approach.

May 18, 2026

Roche acquires PathAI for ~$1.05 billion

Swiss-based multinational healthcare company Roche has agreed to acquire PathAI, a US-based AI-powered digital pathology firm, for ~$1.05 billion. Roche will pay $750 million upfront and additional milestone payments of up to $300 million.

May 14, 2026

HBI 2026: Unleashing prevention; Models deploying genomics at scale

Speakers at HBI’s 2026 conference working on various projects attempting to harness the latent potential of genomic data shared some insights they’d gained from this at a session entitled ‘Unleashing prevention: Models deploying genomics at scale’.

May 14, 2026

Columna Capital buys Evidenze Group from Buenavista Equity Partners

London-based private equity firm Columna Capital has acquired a majority stake in Evidenze Group, a pan-European outsourced pharma services company, from Madrid-based Buenavista Equity Partners.

Life Sciences

June 11, 2026

June 11, 2026

May 27, 2026

May 22, 2026

May 21, 2026

May 21, 2026

May 18, 2026

May 14, 2026

May 14, 2026

May 7, 2026

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.